rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches )

Background: Zaire Ebolavirus disease (EVD) outbreaks can be controlled using rVSV-ZEBOV vaccination and other public health measures. People in high-risk areas may have pre-existing antibodies from asymptomatic Ebolavirus exposure that might affect response to rVSV-ZEBOV. Therefore, we assessed the...

Full description

Bibliographic Details
Main Authors:	Watson, CH, Gsell, P, Hall, Y, Camacho, A, Riveros, X, Enwere, G, Vicari, A, Nadlaou, SD, Toure, A, Sani, IM, Diallo, A, Kolie, C, Duraffour, S, Ifono, K, Maomou, A, Dore, K, Djidonou, HA, Bagayoko, A, Damey, PP, Camara, MN, Diallo, FB, Oumar, FT, Toure, K, Diaby, ML, Tipton, T, Carroll, MW
Format:	Journal article
Language:	English
Published:	BioMed Central 2024

rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches )

Similar Items